PURPOSE: To evaluate the immediate and 1-year clinical outcomes of mechanical thrombectomy with use of the Arrow-Trerotola @entity1652 ( @entity1652 ) with or without low-dose urokinase in the treatment of acute iliofemoral @entity1150 ( @entity1150 ). MATERIALS AND METHODS: Mechanical thrombectomy with the @entity1652 was performed in 25 @entity1 with acute iliofemoral @entity1150 . Thrombolytic therapy with low-dose urokinase was used in all @entity1 without contraindications (n = 20). Other therapies used in combination included inferior vena cava filter insertion (n = 5), sheath aspiration thrombectomy (n = 25), and angioplasty and stent placement (n = 20). RESULTS: Initial technical and clinical success was achieved in all cases. In the 20 @entity1 who had no contraindications to the use of urokinase, the dosage of urokinase did not exceed 1 million IU (range, 360,000-1,000,000 IU; mean, 640,000 IU). The mean time of urokinase infusion was 16 hours (range, 12-20). In five @entity1 who had a contraindication to the use of urokinase, mechanical thrombectomy with the @entity1652 was successful without the use of urokinase. There were no major complications. Primary patency of the stent-implanted common iliac vein segment was achieved at 1 year in 17 of 20 @entity1 (85%). The overall 1-year clinical success rate was 92% (23 of 25 @entity1 ). @entity340 occurred in two @entity1 (8%). CONCLUSION: The @entity1652 is an effective mechanical thrombectomy device in the treatment of acute iliofemoral @entity1150 with or without adjunctive urokinase thrombolysis.

Mechanical thrombectomy of acute iliofemoral @entity1150 with use of an Arrow-Trerotola XXXX .

@entity1652 :: ('MESH:D009471', 'Disease') :: ['percutaneous thrombectomy device', 'PTD'] @entity1150 :: ('MESH:D020246', 'Disease') :: ['deep vein thrombosis', 'DVT'] @entity1 :: ('9606', 'Species') :: ['patients'] @entity340 :: ('MESH:D006349', 'Disease') :: ['Valvular insufficiency']
@entity1652 :: (MESH:D009471,Disease) :: ['percutaneous thrombectomy device']
